Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Sands Capital
AddedFeb 11, 2024
UpdatedJul 7, 2026
Sands Capital

Sands Capital

Operating

Sands Capital is an Arlington, Virginia-based investment management firm founded in 1992 that provides growth-oriented investment strategies globally.

Location
Arlington, VA, US
Founded
1992
Firm
Compare
Portfolio
Employees
News
Website

Investments

Baseten
Baseten
Series F

Total Raised

$2.1B

Rounds

8

Series F$1.5BJune 2026
Anduril Industries
Anduril Industries

Total Raised

$11.2B

Rounds

10

Series G$2.5BJune 2025
Series F$1.5BAugust 2024
Rippling
Rippling
Series G

Total Raised

$1.6B

Rounds

8

Series G$450MMay 2025
Elephas
Elephas

Total Raised

$123.5M

Rounds

5

Series C$55MNovember 2023
Series B$41.5MSeptember 2022
Cytovale
Cytovale

Total Raised

$128.6M

Rounds

9

Series C$84MNovember 2023
SafeRide
SafeRide

Total Raised

$2.8M

Rounds

6

Series COctober 2023
Beta Bionics
Beta Bionics

Total Raised

$293.5M

Rounds

8

Series D$100MAugust 2023
Ramp
Ramp
Acquired

Total Raised

$2.1B

Rounds

12

Series D$300MAugust 2023
OneTrust
OneTrust

Total Raised

$1.1B

Rounds

7

Private Equity$150MJuly 2023
Luminoah
Luminoah

Total Raised

$6M

Rounds

2

Series A$6MJune 2023
Hungry Marketplace
Hungry Marketplace

Total Raised

$70.2M

Rounds

7

Series C$10MJune 2023
pgEdge
pgEdge

Total Raised

$9M

Rounds

1

Seed$9MMarch 2023
Snyk
Snyk

Total Raised

$1.2B

Rounds

13

Series G$196.5MDecember 2022
Tellius
Tellius

Total Raised

$33M

Rounds

4

Series B$16MOctober 2022
Vitara Biomedical
Vitara Biomedical

Total Raised

$115M

Rounds

2

Series B$75MSeptember 2022
Cleerly
Cleerly

Total Raised

$280.5M

Rounds

3

Series C$223MJuly 2022
Inspirna
Inspirna

Total Raised

$144.6M

Rounds

6

Series D$55.1MJuly 2022
LimaCharlie
LimaCharlie

Total Raised

$6M

Rounds

2

Seed$5.5MMay 2022
Redbud Brands
Redbud Brands

Total Raised

$66.6M

Rounds

4

Series Unknown$46MMay 2022
Credo AI
Credo AI

Total Raised

$18.3M

Rounds

2

Series A$12.8MMay 2022
Selux Diagnostics
Selux Diagnostics

Total Raised

$172.5M

Rounds

9

Series C$50MFebruary 2022
Day Zero Diagnostics
Day Zero Diagnostics

Total Raised

$63M

Rounds

12

Series Unknown$21MFebruary 2022
Codoxo
Codoxo

Total Raised

$14.7M

Rounds

6

Series B$5.2MFebruary 2022